| 摘要 |
A family of compounds having general structural formula (I) where W is a reverse hydroxamic acid group, and R1, R2, R3, R4, R5 and R6 are as described in the specification, or a pharmaceutically acceptable salt, solvate, biohydrolyzable ester, biohydrolyzable amide, affinity reagent, or prodrug thereof. Also described are methods for their preparation, pharmaceutical compositions including such compounds and their use in medicine.
|
| 申请人 |
GLAXO GROUP LIMITED;ANDREWS, ROBERT, CARL;ANDERSEN, MARC, WERNER;STANFORD, JENNIFER, BADIANG;BUBACZ, DULCE, GARRIDO;CHAN, JOSEPH, HOWING;COWAN, DAVID, JOHN;GAUL, MICHAEL, DAVID;MCDOUGALD, DARRYL, LYNN;MUSSO, DAVID, LEE;RABINOWITZ, MICHAEL, HOWARD;WIETHE, ROBERT, WILLIAM |
发明人 |
ANDREWS, ROBERT, CARL;ANDERSEN, MARC, WERNER;STANFORD, JENNIFER, BADIANG;BUBACZ, DULCE, GARRIDO;CHAN, JOSEPH, HOWING;COWAN, DAVID, JOHN;GAUL, MICHAEL, DAVID;MCDOUGALD, DARRYL, LYNN;MUSSO, DAVID, LEE;RABINOWITZ, MICHAEL, HOWARD;WIETHE, ROBERT, WILLIAM |
